How long-read sequencing technologies are becoming smaller, cheaper and more accessible.
Genetic counsellor, Anna Middleton explains how the advent of genomics is changing the way that counsellors work.
Carl Zimmer, columnist at The New York Times, shares advice about science writing and communication.
Aubrey de Grey of SENS Research Foundation is working to cure ageing.
In conversation with BERG’s Niven Narain about changing drug development through artificial intelligence.
How can we involve patients in the research that will affect their lives?
From Issue 5 of FLG Magazine, Illumina CEO Jay Flatley answers our questions on long reads, single molecules, and $1000 genomes.
We chat with James Sietstra, President of Seven Bridges, about the Cancer Genomics Cloud and enabling collaboration.
We chat with Genomics plc CEO John Colenutt about big data and what they’ll be up to Festival of Genomics
Answering your questions from Issue 4 of FLG Magazine
Marnie Gelbart of the Personal Genetics Education Project discusses how information can empower patients.
What better way to meet people outside of you area of expertise developing genomic new ideas, than by enjoying a nice cup of morning coffee overlooking the Pacific Ocean?
Ahead of Festival of Genomics in California, Dr Tom Fowler of Genomics England gave us valuable insight into how to manage a large-scale sequencing project
Ahead of the launch of Molecular Case Studies, Editor in Chief Elaine Mardis told us the story behind this new journal.
We talk pharmacogenomics with Jean-Claude Marshall of Pfizer: where the focus should be, next generation sequencing and the FDA’s draft guidance for LDTS.